researchers at edinburgh university and mcgill university in canada identified a chemical pathway that goes awry in the brains of ` fragile x ' patients .
they say the cancer drug could block the pathway and reverse their behavioural symptoms .
the drug blocks a rogue pathway in the brain that causes behavioural symptoms -lrb- file photo -rrb- .
it can also lead to more serious intellectual disabilities , delays in speech and language development development and problems with social interactions .